This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Anthera Pharmaceuticals Inc (ANTH)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 2.64M 25.95M 19.43M 65.62M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 50.00K 0.00
Total Current Assets 3.02M 26.30M 25.18M 67.98M
Property, Plant & Equipment, Gross 1.63M 1.63M 1.61M 1.41M
Accumulated Depreciation & Depletion 1.16M 816.00K 463.00K 132.00K
Property, Plant & Equipment, Net 468.00K 812.00K 1.15M 1.28M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 10.30M 116.00K 240.00K
Total Non-Current Assets 468.00K 11.11M 1.27M 1.52M
Liabilities & Shareholder Equity
Total Assets 3.49M 37.42M 26.44M 69.49M
Accounts Payable 2.23M 3.52M 5.21M 17.43M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.00M 0.00 0.00 0.00
Total Current Liabilities 5.75M 7.56M 18.75M 30.24M
Long Term Debt 0.00 15.10M 11.22M 20.17M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 15.10M 11.22M 20.17M
Total Liabilities 5.75M 22.66M 29.97M 50.41M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -2.26M 14.76M -3.53M 19.08M
Common Par 23.00K 19.00K 79.00K 41.00K
Additional Paid In Capital 314.53M 301.95M 256.79M 220.05M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -316.81M -287.21M -260.38M -200.98M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 -17.00K -29.00K
Total Capitalization -2.26M 29.86M 7.70M 39.26M
Total Equity -2.26M 14.76M -3.53M 19.08M
Total Liabilities & Stock Equity 3.49M 37.42M 26.44M 69.49M
Total Common Shares Outstanding 23.01M 19.42M 9.89M 5.12M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 21.78M 18.27M 7.23M 4.68M
Diluted Weighted Shares Outstanding 21.78M 18.27M 7.23M 4.68M
Number of Employees 20 25 23 38
Number of Part-Time Employees 0 0 0 0

ANTH Anthera Pharmaceuticals Inc

Chart of ANTH

Analysts Ratings for ANTH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ANTH Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs